KDR and brain neoplasm: Eight days after initiation of the treatment murine PDGF-C in the tumor extract was significantly increased (p = 0.041) compared to control brain (Figure 6) confirming that PDGF-C is possibly involved in resistance to anti-VEGFR2 therapy in brain tumors as well.